Importance of ACLS Tachycardia Algorithm
The ACLS tachycardia algorithm removes guesswork during emergencies by providing healthcare providers with a clear, step-by-step framework. Like any other ACLS algorithm, this algorithm also reduces treatment mistakes and speeds up response times. As a result, patients get better results.
The tachycardia algorithm is beneficial for healthcare providers as it positively impacts patients’s end results. It also guides healthcare providers through accurate assessment of hemodynamic stability, helping them quickly identify patients who need immediate intervention. The tachycardia protocol focuses on proper rhythm identification by helping providers differentiate between narrow and wide QRS complexes.
Additionally, this algorithm provides clear intervention guidelines, including specific medication dosages and cardioversion protocols. It also helps clinicians identify and manage reversible causes that may be triggering the tachycardia.
Important Steps of the Tachycardia Algorithm

The ACLS tachycardia algorithm guides healthcare providers for treating patients with tachycardia. Following these steps reduces errors and improves accuracy for better results.
Here are the important steps of the tachycardia algorithm:
Step 1: Confirm Tachycardia
Measure the patient’s heart rate to verify tachycardia, typically at 150 beats per minute or higher. Some patients may show instability at lower rates depending on their condition. Check for a pulse within 10 seconds. If no pulse is detected, immediately switch to the ACLS cardiac arrest algorithm. Only proceed with the tachycardia algorithm when you confirm a clear, palpable pulse and a heartbeat above 150 bpm.
Step 2: Establish Basic Support and Monitoring
Secure the patient’s airway and assist breathing if a respiratory problem happens. Provide supplemental oxygen to maintain saturation between 94% and 99% for hypoxemic patients. At the same time, check the heart rhythm and blood pressure, set up a pulse oximeter, insert an IV line, and perform a 12-lead ECG.
Step 3: Identify and Address Underlying Causes
Assess reversible causes that may trigger tachycardia while providing supportive care. Reversible causes can be identified by using the Hs and Ts framework of the ACLS algorithm. Treat these underlying conditions at the same time as rhythm management and patient assessment. Fixing the root cause can positively affect treatment response and improve patient outcomes.
Step 4: Assess Patient Stability
Understand hemodynamic stability through a systematic evaluation of key clinical indicators. Unstable patients have symptoms like hypotension, altered mental status, signs of shock, ischemic chest discomfort, or acute heart failure. However, stable patients maintain adequate blood pressure and organ perfusion despite fast heart rates. This stability assessment is important to decide treatment urgency and selection of intervention.
Step 5: Provide Treatment Based on Stability
The treatment approach depends directly on the patient’s stability. Unstable patients require immediate intervention, while stable patients need more rhythm-specific treatment.
For Unstable Patients
Immediate Synchronized Cardioversion:
Unstable patients with signs of shock, hypotension, or altered mental status require immediate synchronized cardioversion. Apply sedation if possible and use sync mode to avoid delivering energy during the T-wave. Energy selection depends on rhythm characteristics:
- Narrow regular complexes start at 50-100 joules
- Narrow irregular rhythms need 120-200 joules
- Wide regular patterns begin at 100 joules
For wide irregular rhythms, turn off synchronization and defibrillate immediately.
For Stable Patients
Wide QRS
Stable patients with wide QRS complexes require careful rhythm analysis and medication selection. Consider adenosine only if the rhythm is regular and monomorphic. For other wide-complex rhythms, use antiarrhythmic infusions like procainamide, amiodarone, or sotalol. Avoid these medications in patients with prolonged QT intervals or heart failure. Expert consultation is also recommended to ensure safe and effective management of tachycardia.
Narrow QRS
Stable patients with narrow QRS complexes typically respond well to vagal maneuvers and adenosine. Try vagal maneuvers first if the rhythm is regular. If unsuccessful, consider adenosine 6 mg rapid IV push for regular rhythm followed by a normal saline flush, then 12 mg if needed. For persistent narrow-complex tachycardia, consider beta-blockers or calcium channel blockers as appropriate.
Final Assessment
If the patient remains refractory to initial treatment, healthcare providers must reassess the situation. Evaluate the underlying cause more thoroughly, as missed reversible conditions like hypoxia or toxins may be preventing successful rhythm conversion. Consider increasing the energy level for the next cardioversion attempt and adding antiarrhythmic drugs to improve success rates. Also, consider expert consultation for complex cases or when standard treatments fail to restore stable rhythm.
AHA ACLS Certification and Recertification
- Compliant with AHA Guidelines
- Available anytime, anywhere
- Nationally accepeted course
- Instant Certification Provided
ACLS Resource Link
Medications Used in the AHA Tachycardia Algorithm
The tachycardia algorithm, also known as the tachyarrhythmia algorithm, uses specific medications based on rhythm type and patient stability. Healthcare providers must select the appropriate drug and dosing guideline to manage different tachyarrhythmia conditions effectively.
- Adenosine: Works for regular, narrow-complex tachycardias. The standard dose is a 6 mg rapid IV push with a normal saline flush, followed by 12 mg if the first dose doesn’t work.
- Procainamide: Treats stable wide-QRS tachycardia at 20-50 mg/min until the rhythm converts or reaches 17 mg/kg maximum. Maintenance continues at 1-4 mg/min but should be avoided in patients with prolonged QT or heart failure.
- Amiodarone: Treats wide-complex tachycardias, starting with 150 mg over 10 minutes. The dose can be repeated if ventricular tachycardia returns, then maintained at 1 mg/min for the first six hours.
- Sotalol: Used for stable wide-complex tachycardias. The dose is 100 mg (1.5 mg/kg) given over five minutes. Also, avoid in patients with prolonged QT syndrome.
Reversible Causes in the ACLS Tachycardia Algorithm?
Healthcare providers must identify and treat reversible causes during tachycardia management, commonly known as the “H’s and T’s.”
The H’s Include:
- Hypoxia: Insufficient oxygen delivery from respiratory problems or airway obstruction causes the heart to beat faster to compensate.
- Hypovolemia: Low blood volume from bleeding, dehydration, or fluid loss reduces cardiac output and causes tachycardia.
- Hydrogen ions (Acidosis): Acidic blood from diabetic ketoacidosis, shock, or respiratory failure disrupts normal electrical conduction in the heart.
- Hypo/Hyperkalemia: Abnormal potassium levels impact heart electrical activity. Low potassium can lead to arrhythmias, while high potassium may cause heart blocks.
- Hypothermia: When body temperature drops, cellular metabolism slows. This can lead to arrhythmias like tachycardia.
Secondary Assessment:
- Toxins: Drug overdoses, poisoning, or medication side effects can directly affect cardiac electrical systems and cause rhythm disturbances.
- Tamponade (Cardiac): Fluid accumulation around the heart restricts cardiac filling and triggers tachycardia.
- Tension Pneumothorax: A collapsed lung with increasing pressure reduces venous return to the heart and causes rapid heart rates.
- Thrombosis (Pulmonary): Blood clots in the lungs increase heart workload and cause tachycardia.
- Thrombosis (Coronary): A heart attack from blocked coronary arteries triggers arrhythmias and rapid heart rates as damaged heart muscle affects conduction.
Our Courses
Frequently Asked Questions
What Drugs Are Used for Tachycardia in ACLS?
ACLS drugs for tachycardia are adenosine for regular narrow-complex tachycardia, amiodarone for stable wide-complex ventricular tachycardia, and procainamide and sotalol as alternatives for wide-complex tachycardia.
When to Give Adenosine Vs. Amiodarone?
Adenosine is given for stable, regular narrow-complex tachycardia, while amiodarone is given for stable wide-complex ventricular tachycardia or arrhythmias refractory to other treatments.
How Many Joules Is a Tachycardia ACLS?
For synchronized cardioversion in tachycardia, initial energy doses are typically 50-100 joules for narrow regular QRS, 120-200 joules for narrow irregular QRS, and 100 joules for wide regular QRS complexes.



